157 related articles for article (PubMed ID: 29735548)
21. β-catenin regulates NF-κB activity via TNFRSF19 in colorectal cancer cells.
Schön S; Flierman I; Ofner A; Stahringer A; Holdt LM; Kolligs FT; Herbst A
Int J Cancer; 2014 Oct; 135(8):1800-11. PubMed ID: 24623448
[TBL] [Abstract][Full Text] [Related]
22. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
[TBL] [Abstract][Full Text] [Related]
23. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
[TBL] [Abstract][Full Text] [Related]
25. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
27. TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin Signaling.
Zuo X; Wang X; Ma T; Chen S; Cao P; Cheng H; Yang N; Han X; Gao W; Liu X; Sun Y
Mol Cancer Res; 2024 Mar; 22(3):227-239. PubMed ID: 38047807
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
29. Glycoprotein M6B Interacts with TβRI to Activate TGF-β-Smad2/3 Signaling and Promote Smooth Muscle Cell Differentiation.
Zhang X; Xie H; Chang P; Zhao H; Xia Y; Zhang L; Guo X; Huang C; Yan F; Hu L; Lin C; Li Y; Xiong Z; Wang X; Li G; Deng L; Wang S; Tao L
Stem Cells; 2019 Feb; 37(2):190-201. PubMed ID: 30372567
[TBL] [Abstract][Full Text] [Related]
30. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
31. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
32. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
34. Critical regulation of TGFbeta signaling by Hsp90.
Wrighton KH; Lin X; Feng XH
Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9244-9. PubMed ID: 18591668
[TBL] [Abstract][Full Text] [Related]
35. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Kretzschmar M; Doody J; Timokhina I; Massagué J
Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
[TBL] [Abstract][Full Text] [Related]
36. TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type.
Grand Moursel L; Munting LP; van der Graaf LM; van Duinen SG; Goumans MTH; Ueberham U; Natté R; van Buchem MA; van Roon-Mom WMC; van der Weerd L
Brain Pathol; 2018 Jul; 28(4):495-506. PubMed ID: 28557134
[TBL] [Abstract][Full Text] [Related]
37. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.
Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH
Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701
[TBL] [Abstract][Full Text] [Related]
38. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
39. TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2.
Papadimitriou E; Kardassis D; Moustakas A; Stournaras C
Cell Physiol Biochem; 2011; 28(2):229-38. PubMed ID: 21865730
[TBL] [Abstract][Full Text] [Related]
40. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
Zhang Y; Zhang W
Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
